1143 related articles for article (PubMed ID: 32827168)
41. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.
Naik S; Lepine S; Nagels HE; Siristatidis CS; Kroon B; McDowell S
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD009749. PubMed ID: 38837771
[TBL] [Abstract][Full Text] [Related]
42. Hyaluronic acid in embryo transfer media for assisted reproductive technologies.
Heymann D; Vidal L; Or Y; Shoham Z
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD007421. PubMed ID: 32876946
[TBL] [Abstract][Full Text] [Related]
43. Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006.
JOINT SOGC-CFAS
Int J Gynaecol Obstet; 2008 Aug; 102(2):203-16. PubMed ID: 18773532
[TBL] [Abstract][Full Text] [Related]
44. Effect of frozen-thawed embryo transfer with a poor-quality embryo and a good-quality embryo on pregnancy and neonatal outcomes.
Zeng C; Lu RH; Li X; Wang S; Kuai YR; Xue Q
Reprod Biol Endocrinol; 2024 Feb; 22(1):26. PubMed ID: 38383391
[TBL] [Abstract][Full Text] [Related]
45. Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI.
Kalampokas T; Pandian Z; Keay SD; Bhattacharya S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004752. PubMed ID: 28349525
[TBL] [Abstract][Full Text] [Related]
46. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles.
Boomsma CM; Kamath MS; Keay SD; Macklon NS
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD005996. PubMed ID: 35771604
[TBL] [Abstract][Full Text] [Related]
47. Culture media for human pre-implantation embryos in assisted reproductive technology cycles.
Youssef MM; Mantikou E; van Wely M; Van der Veen F; Al-Inany HG; Repping S; Mastenbroek S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007876. PubMed ID: 26585317
[TBL] [Abstract][Full Text] [Related]
48. Intracytoplasmic sperm injection versus conventional in vitro fertilisation in couples with males presenting with normal total sperm count and motility.
Cutting E; Horta F; Dang V; van Rumste MM; Mol BWJ
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD001301. PubMed ID: 37581383
[TBL] [Abstract][Full Text] [Related]
49. Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction.
Craciunas L; Tsampras N; Coomarasamy A; Raine-Fenning N
Cochrane Database Syst Rev; 2016 May; (5):CD011537. PubMed ID: 27195724
[TBL] [Abstract][Full Text] [Related]
50. Population trends and live birth rates associated with common ART treatment strategies.
Chambers GM; Wand H; Macaldowie A; Chapman MG; Farquhar CM; Bowman M; Molloy D; Ledger W
Hum Reprod; 2016 Nov; 31(11):2632-2641. PubMed ID: 27664207
[TBL] [Abstract][Full Text] [Related]
51. Antioxidants for male subfertility.
Showell MG; Mackenzie-Proctor R; Brown J; Yazdani A; Stankiewicz MT; Hart RJ
Cochrane Database Syst Rev; 2014; (12):CD007411. PubMed ID: 25504418
[TBL] [Abstract][Full Text] [Related]
52. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection.
Twisk M; Mastenbroek S; van Wely M; Heineman MJ; Van der Veen F; Repping S
Cochrane Database Syst Rev; 2006 Jan; (1):CD005291. PubMed ID: 16437524
[TBL] [Abstract][Full Text] [Related]
53. Post-embryo transfer interventions for assisted reproduction technology cycles.
Abou-Setta AM; Peters LR; D'Angelo A; Sallam HN; Hart RJ; Al-Inany HG
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006567. PubMed ID: 25157849
[TBL] [Abstract][Full Text] [Related]
54. Interventions for unexplained infertility: a systematic review and network meta-analysis.
Wang R; Danhof NA; Tjon-Kon-Fat RI; Eijkemans MJ; Bossuyt PM; Mochtar MH; van der Veen F; Bhattacharya S; Mol BWJ; van Wely M
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD012692. PubMed ID: 31486548
[TBL] [Abstract][Full Text] [Related]
55. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.
Nagels HE; Rishworth JR; Siristatidis CS; Kroon B
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009749. PubMed ID: 26608695
[TBL] [Abstract][Full Text] [Related]
56. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
Ngwenya O; Lensen SF; Vail A; Mol BWJ; Broekmans FJ; Wilkinson J
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD012693. PubMed ID: 38174816
[TBL] [Abstract][Full Text] [Related]
57. Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies.
Siristatidis CS; Sertedaki E; Vaidakis D; Varounis C; Trivella M
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011872. PubMed ID: 29547689
[TBL] [Abstract][Full Text] [Related]
58. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes.
Roque M; Haahr T; Geber S; Esteves SC; Humaidan P
Hum Reprod Update; 2019 Jan; 25(1):2-14. PubMed ID: 30388233
[TBL] [Abstract][Full Text] [Related]
59. Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination.
Bui BN; Lensen SF; Gibreel A; Martins WP; Torrance H; Broekmans FJ
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011424. PubMed ID: 33734431
[TBL] [Abstract][Full Text] [Related]
60. Trade-off between double cleavage-stage embryos transfer and single blastocyst-stage embryo transfer in patients with few good quality embryos in antagonist cycles: a retrospective study using a propensity score matching analysis.
Han Y; Deng X; Cai J; Peng W; Duan C; Huang K
BMC Pregnancy Childbirth; 2024 May; 24(1):339. PubMed ID: 38702596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
